Abstract
Background. Few studies have characterized the role of sex on the incidence of invasive pneumococcal disease (IPD). We examined sex differences in rates of IPD, and trends after the introduction of pneumococcal conjugate vaccines (PCVs). Methods. We used active population and laboratory-based IPD surveillance data from the Centers for Disease Control and Prevention Active Bacterial Core surveillance program (1998–2013) in Tennessee. Population-based rates of IPD by sex, race, age group, and PCV era were calculated. Rates were compared using incidence rate ratios. Results. Throughout the study years, rates of IPD were higher in male than in female subjects, particularly in children 74 years of age. Conclusions. Rates of IPD were generally higher in male than in female subjects. These sex differences were observed in different race groups and persisted after introduction of both PCVs.
Funding Information
  • Pfizer (ASPIRE award)
  • Healthcare Research and Quality (1R03HS022342)
  • Centers for Disease Control and Prevention (5-U50-CK000198-3)
  • National Institutes of Health (T32 AI095202)

This publication has 24 references indexed in Scilit: